Eccrine poromatosis in a patient with acute myeloid leukemia following chemotherapy
Garshick, M.; DeFilippis, E.M.; Harp, J.; Gaan, J.
Dermatology Online Journal 20(11)
2014
ISSN/ISBN: 1087-2108 PMID: 25419754 Document Number: 678016
Eccrine poromas are rare, benign adnexal tumors that often occur as solitary papules. Rarely, eccrine poromas can present as multiple lesions, which is referred to as eccrine poromatosis. We report a case of eccrine poromatosis occuring on the palms and soles occuring after chemotherapy in a patient with a history of acute myeloid leukemia.
Document emailed within 1 workday
Related Documents
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40Yoshida, M.; Ogawa, K.; Sakamoto, H.; Motomura, S.; Ishigatsubo, Y. 2000: Syndrome of inappropriate secretion of antidiuretic hormone in a patient with myeloid antigen positive acute lymphoblastic leukemia after systemic chemotherapy including vincristine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(1): 99-102
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Machover, D.; Schwarzenberg, L.; D'Hubert, E.; Lemaigre, G.; Caillou, B.; Tourani, J.M.; Michalski, B.; Goldschmidt, E.; Gaget, H.; De Vassal, F.; Misset, J.L.; Dorval, T.; Ribaud, P.; Jasmin, C.; Hayat, M.; Rappaport, H.; Mathé, G. 1982: Treatment of acute myeloid leukemia with a protocol combining intensive induction chemotherapy, early consolidation treatment, splenectomy and long-term maintenance chemotherapy. Preliminary study La Nouvelle Presse Medicale 11(52): 3835-3839
Koistinen, P.; Ruuska, S.; Saily, M.; Kakko, S.; Siitonen, P.; Siitonen, T.; Savolainen, M.J.; Kinnula, V.L.; Savolainen, E-Riitta. 2006: An association between manganese superoxide dismutase polymorphism and outcome of chemotherapy in acute myeloid leukemia Haematologica 91(6): 829-832
Tartas, N.; Grassi, D. 1991: Controversies in the treatment of acute myeloid leukemia of the adult. Chemotherapy vs bone marrow transplantation Medicina 51(4): 361-364
Del Palacio Pérez-Medel, A.; Fernández-Rañada, J.M.; Montero Castillo, J.; Pozuelo González, A.; Schuller Perez, A. 1977: Acute myeloid leukemia and multiple neoplasms in the same patient Revista Clinica Espanola 144(2): 151-153
Nawata, R.; Shinohara, K.; Yamada, T.; Takahashi, T.; Katsuki, K.; Takeda, K.; Kameda, N.; Ariyoshi, K.; Ota, I.; Muraki, K. 2000: Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses International Journal of Hematology 71(4): 353-358
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Lilly, E.; Granter, S.R.; Haynes, H.A.; Ibrahimi, O.A. 2012: Chemotherapy-induced inflammatory seborrheic keratoses in a man with acute myeloid leukemia: a variant of Leser-Trélat sign? Cutis 90(5): 235-236
Jiménez, C.; Capdevila, J.A.; Hidalgo, A. 1999: Invasive pulmonary aspergillosis in a patient with acute myeloid leukemia Haematologica 84(12): 1150
Nakayama, S.; Ishikawa, T.; Yabe, H.; Nagai, K.; Kasakura, S.; Uchino, H. 1988: Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3 Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(6): 1026-1030
Ng, K.P.; Soo-Hoo, T.S.; Na, S.L.; Gan, G.G.; Sangkar, J.V.; Teh, A.K. 2003: Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia Medical Journal of Malaysia 58(4): 608-612
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Bhatia, N.; Wallace, T.; Divgi, A.; Short, V. 2007: Myeloid sarcoma presenting as an isolated nodule in a patient with acute myelogenous leukemia Journal of Drugs in Dermatology: Jdd 6(4): 447-450
Mustjoki, S.; Sidenius, N.; Sier, C.F.; Blasi, F.; Elonen, E.; Alitalo, R.; Vaheri, A. 2000: Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy Cancer Research 60(24): 7126-7132
Siddiqui, T.; Durkin, W.J.; Conley, N.S.; Doughney, K.B.; Favis, G.R.; Weiss, R.; Smith, A.E. 1994: Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia Journal of the Florida Medical Association 81(7): 475-477
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376